These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

324 related items for PubMed ID: 20203687

  • 1. Heme-arginate suppresses phospholipase C and oxidative stress in the mesenteric arterioles of mineralcorticoid-induced hypertensive rats.
    Ndisang JF, Jadhav A.
    Hypertens Res; 2010 Apr; 33(4):338-47. PubMed ID: 20203687
    [Abstract] [Full Text] [Related]

  • 2. Heme arginate therapy enhanced adiponectin and atrial natriuretic peptide, but abated endothelin-1 with attenuation of kidney histopathological lesions in mineralocorticoid-induced hypertension.
    Ndisang JF, Jadhav A.
    J Pharmacol Exp Ther; 2010 Jul; 334(1):87-98. PubMed ID: 20392817
    [Abstract] [Full Text] [Related]

  • 3. Treatment with heme arginate alleviates adipose tissue inflammation and improves insulin sensitivity and glucose metabolism in a rat model of Human primary aldosteronism.
    Jadhav A, Ndisang JF.
    Free Radic Biol Med; 2012 Dec 15; 53(12):2277-86. PubMed ID: 23089228
    [Abstract] [Full Text] [Related]

  • 4. The heme oxygenase system attenuates pancreatic lesions and improves insulin sensitivity and glucose metabolism in deoxycorticosterone acetate hypertension.
    Ndisang JF, Jadhav A.
    Am J Physiol Regul Integr Comp Physiol; 2010 Jan 15; 298(1):R211-23. PubMed ID: 19864334
    [Abstract] [Full Text] [Related]

  • 5. Crosstalk between the heme oxygenase system, aldosterone, and phospholipase C in hypertension.
    Ndisang JF, Lane N, Jadhav A.
    J Hypertens; 2008 Jun 15; 26(6):1188-99. PubMed ID: 18475157
    [Abstract] [Full Text] [Related]

  • 6. Heme arginate suppresses cardiac lesions and hypertrophy in deoxycorticosterone acetate-salt hypertension.
    Jadhav A, Ndisang JF.
    Exp Biol Med (Maywood); 2009 Jul 15; 234(7):764-78. PubMed ID: 19429856
    [Abstract] [Full Text] [Related]

  • 7. Heme oxygenase suppresses markers of heart failure and ameliorates cardiomyopathy in L-NAME-induced hypertension.
    Ndisang JF, Chibbar R, Lane N.
    Eur J Pharmacol; 2014 Jul 05; 734():23-34. PubMed ID: 24726875
    [Abstract] [Full Text] [Related]

  • 8. Hemin therapy attenuates kidney injury in deoxycorticosterone acetate-salt hypertensive rats.
    Jadhav A, Torlakovic E, Ndisang JF.
    Am J Physiol Renal Physiol; 2009 Mar 05; 296(3):F521-34. PubMed ID: 19116243
    [Abstract] [Full Text] [Related]

  • 9. Interaction among heme oxygenase, nuclear factor-kappaB, and transcription activating factors in cardiac hypertrophy in hypertension.
    Jadhav A, Torlakovic E, Ndisang JF.
    Hypertension; 2008 Nov 05; 52(5):910-7. PubMed ID: 18824663
    [Abstract] [Full Text] [Related]

  • 10. Upregulating the heme oxygenase system suppresses left ventricular hypertrophy in adult spontaneously hypertensive rats for 3 months.
    Ndisang JF, Jadhav A.
    J Card Fail; 2009 Sep 05; 15(7):616-28. PubMed ID: 19700139
    [Abstract] [Full Text] [Related]

  • 11. Heme Oxygenase Improves Renal Function by Potentiating Podocyte-Associated Proteins in Nω-Nitro-l-Arginine-Methyl Ester (l-NAME)-Induced Hypertension.
    Ndisang JF, Chibbar R.
    Am J Hypertens; 2015 Jul 05; 28(7):930-42. PubMed ID: 25498996
    [Abstract] [Full Text] [Related]

  • 12. Heme oxygenase-mediated endothelial dysfunction in DOCA-salt, but not in spontaneously hypertensive, rat arterioles.
    Johnson FK, Durante W, Peyton KJ, Johnson RA.
    Am J Physiol Heart Circ Physiol; 2004 May 05; 286(5):H1681-7. PubMed ID: 14693679
    [Abstract] [Full Text] [Related]

  • 13. Heme oxygenase system enhances insulin sensitivity and glucose metabolism in streptozotocin-induced diabetes.
    Ndisang JF, Jadhav A.
    Am J Physiol Endocrinol Metab; 2009 Apr 05; 296(4):E829-41. PubMed ID: 19190261
    [Abstract] [Full Text] [Related]

  • 14. Up-regulating the hemeoxygenase system enhances insulin sensitivity and improves glucose metabolism in insulin-resistant diabetes in Goto-Kakizaki rats.
    Ndisang JF, Jadhav A.
    Endocrinology; 2009 Jun 05; 150(6):2627-36. PubMed ID: 19228889
    [Abstract] [Full Text] [Related]

  • 15. Hemin therapy improves kidney function in male streptozotocin-induced diabetic rats: role of the heme oxygenase/atrial natriuretic peptide/adiponectin axis.
    Ndisang JF, Jadhav A.
    Endocrinology; 2014 Jan 05; 155(1):215-29. PubMed ID: 24140713
    [Abstract] [Full Text] [Related]

  • 16. Upregulation of the heme oxygenase system ameliorates postprandial and fasting hyperglycemia in type 2 diabetes.
    Ndisang JF, Lane N, Jadhav A.
    Am J Physiol Endocrinol Metab; 2009 May 05; 296(5):E1029-41. PubMed ID: 19208858
    [Abstract] [Full Text] [Related]

  • 17. Reduced NO production rapidly aggravates renal function through the NF-κB/ET-1/ETA receptor pathway in DOCA-salt-induced hypertensive rats.
    Kimura K, Ohkita M, Koyama M, Matsumura Y.
    Life Sci; 2012 Oct 15; 91(13-14):644-50. PubMed ID: 22569294
    [Abstract] [Full Text] [Related]

  • 18. Up-regulating the heme oxygenase system with hemin improves insulin sensitivity and glucose metabolism in adult spontaneously hypertensive rats.
    Ndisang JF, Lane N, Syed N, Jadhav A.
    Endocrinology; 2010 Feb 15; 151(2):549-60. PubMed ID: 20016031
    [Abstract] [Full Text] [Related]

  • 19. Endothelin-1-induced oxidative stress in DOCA-salt hypertension involves NADPH-oxidase-independent mechanisms.
    Callera GE, Tostes RC, Yogi A, Montezano AC, Touyz RM.
    Clin Sci (Lond); 2006 Feb 15; 110(2):243-53. PubMed ID: 16271043
    [Abstract] [Full Text] [Related]

  • 20. Reduced NOS3 phosphorylation mediates reduced NO/cGMP signaling in mesenteric arteries of deoxycorticosterone acetate-salt hypertensive rats.
    Sasser JM, Sullivan JC, Elmarakby AA, Kemp BE, Pollock DM, Pollock JS.
    Hypertension; 2004 May 15; 43(5):1080-5. PubMed ID: 14993198
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.